Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Potential pharmaceutical drugs in the field of cancer

27.12.2005


Raquel Villar Becares, in her PhD thesis at the Public University of Navarre, has developed new derivatives of benzo[b]tiophene 1,1-dioxide that enable their application in the pharmaceutical field. Moreover, the researcher tested for the antitumoural activity of these derivatives, concluding that 23 of the 24 compounds analysed proved to be active or very active against one or more of the tumoural cell lines tested.



Treatment of diabetes or high blood pressure

Although benzo[b]tiophene 1,1-dioxide, found in both crude and processed petroleum oil, was first described in 1893, it was not until the 1950s when it was discovered that the benzo[b]tiophene ring and its derivatives had interesting biological activities for possible use as pesticides, plant growth regulators, analgesics and local anaesthetics and antihistamines, amongst others applications.


In the field of medicine, a bright future is predicted for the possible application of these benzotiophene derivatives as antineoplasic agents. In order to enhance their properties as potential pharmaceutical drugs and to make progress in establishing their mode of action, thus, it was necessary to extend the number of known benzo[b]tiophene derivatives. All this with the end aim of exploring possibilities for their application in the pharmaceutical field as anti-cancer drugs.

The PhD proposed a rational design based on various theoretical methods, thrown up by the new derivatives, the activity of which was subsequently tested. In a parallel manner and, as knowledge was gained about their possible mechanism, Raquel Villar proposed the investigation of possible targets using theoretical docking methods on the protein active structure sites. Subsequently, they were evaluated as cytotoxic agents, tNOX inhibitors and carbonic anhydrase inhibitors.

Anti-tumoural activity

The activity of these new derivatives was tested, concluding that 23 of the 24 compounds analysed proved to be active or very active against one or more tumoural cell lines tested. Thus, the in vitro cytotoxic activity of 24 new derivatives of benzo[b]tiophene 1,1-dioxide were determined for activity against, amongst others: human lung and leukemia fibroblasts.

More specifically, a number of compounds had an in vitro cytotoxicity comparable to the commercial antineoplasic, Doxorrubicina, used as a positive control of activity in the trials carried out for tumoural growth inhibition.

Garazi Andonegi | alfa
Further information:
http://www.basqueresearch.com/berria_irakurri.asp?Gelaxka=1_1&hizk=I&Berri_Kod=843

More articles from Life Sciences:

nachricht A novel socio-ecological approach helps identifying suitable wolf habitats
17.02.2017 | Universität Zürich

nachricht New, ultra-flexible probes form reliable, scar-free integration with the brain
16.02.2017 | University of Texas at Austin

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Switched-on DNA

20.02.2017 | Materials Sciences

Second cause of hidden hearing loss identified

20.02.2017 | Health and Medicine

Prospect for more effective treatment of nerve pain

20.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>